Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for rivaroxaban ...

The hormonal add-back therapy includes oestradiol 1 mg and norethisterone acetate 0.5 mg to help mitigate ... within its acceptable range. In a press release, Helen Knight, director of Medicines ...

The tablets were prepared by direct compression method, along with Kollidon SR as release retardant polymer. The amount of losartan potassium remains fixed (100 mg) for all the three ... Kollidon SR ...

MatePad Pro 13.2: PC-Level Capabilities, Smart Tablet Convenience The new HUAWEI MatePad Pro 13.2 brings PC-level professional office capabilities into the tablet industry through immersive ...

Huawei unveiled a spectacular line-up of audio, wearable, tablets, and foldable products at HUAWEI Innovative Product Launch held in Kuala Lumpur, Malaysia. The launch event saw the release of the ...

Dr. Reddy’s (RDY) Laboratories and Senores Pharmaceuticals announced the launch of Ivermectin Tablets USP, 3 mg, which is bioequivalent and therapeutically equivalent to STROMECTOL Tablets of ...

extended-release tablets for the treatment of Prader-Willi syndrome (PWS) in individuals four years and older who have hyperphagia. The new Prescription Drug User Fee Act (PDUFA) target action ...

Zydus Lifesciences shares were trading flat on October 18 after the company received final approval to manufacture Fludrocortisone Acetate Tablets USP, 0.1 mg from the United States Food and Drug ...